Community/Retail

Pharmacy managers should offer access and incentivize pharmacy staff to take part in self-development activities that can promote self-efficacy.

Pharmacy Times® interviewed Brian Nightengale, president of Good Neighbor Pharmacy, on what’s on the horizon of interest for independent pharmacy in 2021.

Helpful patient education suggestions for the successful management of COVID-19 at home and when it is appropriate to seek medical attention.

Pharmacy Times® interviewed Brian Nightengale, president of Good Neighbor Pharmacy, on his outlook for the future of independent community pharmacy.

The study authors found marked improvements in rates of hazardous prescribing over the 12-month study period and the success of the intervention was sustained at the end.

The COVID-19 pandemic has escalated the burden of psychological distress, including anxiety, depression, post-traumatic stress, and insomnia.

Pharmacy Times® interviewed Brian Nightengale, president of Good Neighbor Pharmacy, on the steps necessary to support the long-term viability of independent community pharmacies.

The federal government also gave pharmacy technicians the authority to administer COVID-19 vaccines under the supervision of a pharmacist.

The participating national pharmacy partners and independent pharmacy networks represent more than 40,000 pharmacy locations and is a key component of the administration’s national strategy to expand access to vaccines.

When conducting a cesarean delivery, the use of a wound infusion pump in combination with enhanced recovery efforts was found to reduce opioid use by more than 80%.

Three international cardiovascular outcomes trials are currently examining the cardioprotective effects of different influenza vaccine formulations.

Stroke is not among the covered diagnoses for cardiac rehab, despite many similar cardiovascular risk factors, according to the study.

Radiologists should be aware of pulmonary artery thrombosis so that they can work with pharmacists to facilitate accurate diagnoses and management techniques.

Pharmacy Times® interviewed Brian Nightengale, president of Good Neighbor Pharmacy, on solutions that can help support independent community pharmacies now and in the future.

Pharmacy Times® interviewed Micah Cost, PharmD, MS, who was recently selected as the new chief executive officer of PQA, on his plans for the future of the organization.

Pharmacy Times interviewed Rob LaHayne, CEO of TouchCare, on how communicating the safety and efficacy of COVID-19 vaccines to the public is an essential piece of the rollout.

Although eating healthier food and moving more are the basics of weight control and obesity treatment, finding ways to help people adhere to a weight-loss regimen is more complicated.

Vaccine hesitancy is a main driver for lower than desired vaccination rates and recent outbreaks of vaccine-preventable illnesses, such as measles, in the United States.

Pharmacy Times® interviewed Brian Nightengale, president of Good Neighbor Pharmacy, on what the implementation of the recent unanimous SCOTUS ruling on Rutledge v. PCMA may look like.

New data from an unreviewed, preprint research article indicate first-dose immunization efficacy of the Pfizer-BioNTech coronavirus 2019 vaccine improves by 51% 13-24 days post administration.

Pharmacy Times interviewed Rob LaHayne, CEO of TouchCare, on what proper screening and protection looks like for health care workers administering the COVID-19 vaccine looks like.

The letter said states where community pharmacists have taken a larger leadership role have seen a much faster distribution of COVID-19 vaccines to vulnerable populations.

Pharmacy Times interviewed Rob LaHayne, CEO of TouchCare, on what can be done now to avoid complications while administering the coronavirus disease 2019 (COVID-19) vaccine.

The level of protection for the single-dose COVID-19 vaccine was 72% in the United States compared to 57% in South Africa at 28 days post-vaccination, suggesting lower efficacy against the emerging South African variant.

Data from a phase 1b/2 trial investigating the treatment of CCA with the combination of silmitasertib plus gemcitabine and cisplatin in comparison with gemcitabine and cisplatin found a statistically significant difference.

The treatment of 5-fluorouracil with levofolinate and irinotecan was found to be well-tolerated and effective as a second-line treatment for patients with gemcitabine-refractory advanced pancreatic cancer.

In the 1800s, snake oil was brought to the American West from China, where it was used in traditional Chinese medicine practices.

In a progress update on COVID-19 vaccine administration and testing in Walgreens pharmacies, speakers discussed the rollout and implementation of the COVID-19 vaccination process in LTC facilities.

With increasing rates of diabetes and its risk factors, the researchers emphasized the urgency of developing effective interventions.

Pharmacy Times interviewed Rob LaHayne, CEO of TouchCare, on how pharmacies and other health care setting can keep their employees and patients safe as they administer the COVID-19 vaccine.